A Comparison of Flow Cytometry-based versus ImmunoSpot- or Supernatant-based Detection of SARS-CoV-2 Spike-specific Memory B Cells in Peripheral Blood
Vaccines · 24.12.2025 · 14 (1) · 20
DOI: 10.3390/vaccines14010020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 24.12.2025. Verfasst von Georgia Stylianou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Science and Environment, School of Geography and Natural Sciences, Northumbria University, Newcastle upon Tyne NE1 8ST, UK. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cellular Technology Limited, R&D budget of Cellular Technology Limited.
Abstract (Originalsprache)
Background
Memory B cells (Bmem) facilitate the generation of renewed and rapid antigen-specific antibody responses long after the initial antigen exposure, at a time when circulating serum antibodies may have declined. As the generation and/or recruitment of Bmem is at the core of most vaccination strategies, the assessment of antigen-specific Bmem is highly informative for forecasting and profiling the elicited B cell immune response.
Methods
The two prevalent techniques used to detect antigen-specific Bmem cells at single-cell resolution are probe-based flow cytometry and B cell ImmunoSpot, while the measurement of B cell-derived antibodies in culture supernatants of stimulated B cells offers a semi-quantitative alternative. To the best of our knowledge, a direct side-by-side comparison of these assay systems has not yet been reported using the same starting PBMC material in a blinded fashion to test all three assays simultaneously.
Results
These three assay systems were run in parallel to detect SARS-CoV-2 Wuhan-1 strain Spike-specific IgG+ Bmem in peripheral blood mononuclear cell (PBMC) samples obtained from well-defined cohorts comprising pre-COVID-19 era “naïve” individuals (negative controls), individuals shortly after recovery from a PCR-verified SARS-CoV-2 infection (positive controls), and a cohort of donor PBMCs isolated in 2024 (the experimental group). Each assay was able to discern Spike-exposed individuals from naïve , with ImmunoSpot suggesting superior sensitivity and specificity. ImmunoSpot and flow cytometry results were closely correlated.
Conclusions
The study demonstrates that all three assays are suited for the detection of specific Bmem in antigen-primed individuals when such Bmem occur in the mid- to high-frequency range, and that they broadly concur. Strengths and weaknesses of the three test systems are discussed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Science and Environment, School of Geography and Natural Sciences, Northumbria University, Newcastle upon Tyne NE1 8ST, UK.
- Translational & Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.
- Research & Development, Cellular Technology Limited, Shaker Heights, OH 44122, USA.
ORCID-Profile: Georgia Stylianou, Sharon Cookson, Greg A Kirchenbaum, Stephen M Todryk
Förderung
- Cellular Technology Limited
- R&D budget of Cellular Technology Limited
Zitieren
APA
Stylianou, G., Cookson, S., Nassif, J. T., Kirchenbaum, G. A., Lehmann, P. V., & Todryk, S. M. (2025). A Comparison of Flow Cytometry-based versus ImmunoSpot- or Supernatant-based Detection of SARS-CoV-2 Spike-specific Memory B Cells in Peripheral Blood. Vaccines, 14(1), 20. https://doi.org/10.3390/vaccines14010020
Vancouver
Stylianou G, Cookson S, Nassif JT, Kirchenbaum GA, Lehmann PV, Todryk SM. A Comparison of Flow Cytometry-based versus ImmunoSpot- or Supernatant-based Detection of SARS-CoV-2 Spike-specific Memory B Cells in Peripheral Blood. Vaccines. 2025;14(1):20. doi:10.3390/vaccines14010020
BibTeX
@article{Stylianou2025,
author = {Stylianou, Georgia and Cookson, Sharon and Nassif, Justin T and Kirchenbaum, Greg A and Lehmann, Paul V and Todryk, Stephen M},
title = {A Comparison of Flow Cytometry-based versus ImmunoSpot- or Supernatant-based Detection of SARS-CoV-2 Spike-specific Memory B Cells in Peripheral Blood},
journal = {Vaccines},
year = {2025},
volume = {14},
number = {1},
pages = {20},
doi = {10.3390/vaccines14010020}
}
EUVIMED